---
title: Endothelial and tumor-intrinsic mechanisms of hepatic melanoma metastasis
date: '2023-10-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37884458/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231027180837&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: The treatment of metastatic cutaneous melanoma was fundamentally improved
  by the discovery and introduction of immune checkpoint inhibitors, such as anti-PD-1
  and anti-CTLA-4 antibodies, and targeted therapy with BRAF and MEK inhibition. Unfortunately,
  many patients suffer a relapse due to resistance mechanisms that in part are mediated
  by organ-specific metastatic sites. Especially, brain and liver metastases are negative
  predictive factors for both treatment modalities. There is still ...
disable_comments: true
---
The treatment of metastatic cutaneous melanoma was fundamentally improved by the discovery and introduction of immune checkpoint inhibitors, such as anti-PD-1 and anti-CTLA-4 antibodies, and targeted therapy with BRAF and MEK inhibition. Unfortunately, many patients suffer a relapse due to resistance mechanisms that in part are mediated by organ-specific metastatic sites. Especially, brain and liver metastases are negative predictive factors for both treatment modalities. There is still ...